Worldwide access to treatment for end-stage kidney disease: a systematic review.

By T. Liyanage, T. Ninomiya, V. Jha, B. Neal, Halle Marie Patrice, I. Okpechi, Ming-hui Zhao, J. Lv, Amit X. Garg, J. Knight and 5 more. The Lancet, 2015

1,988 citations recorded by the source corpus.

Subfields: Nephrology

View Paper: https://www.semanticscholar.org/paper/31d340707f83bb8dae9ebe2369e5c4abec8bb871

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Nephrology

1. A. Levey
2. Josef Coresh
3. Marcello Tonelli
4. Harold I. Feldman
5. A. Levin
6. R. Gansevoort
7. Giuseppe Remuzzi
8. R. Mehta

Citations in the corpus

• The global burden of kidney disease and the sustainable development goals (2018, background): “62 million people received dialysis worldwide and the need for dialysis was projected to double by 2030.(8) Globally,”
• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017, background): “6 million living with a kidney transplant).(6) They further estimated that this only represents approximately 50% of people who need RRT.”
• Chronic kidney disease and the global public health agenda: an international consensus (2024, neutral): “The highest growth in the number of people requiring KRT is projected for Africa, where 23 of the 28 poorest countries in the world are located 22 .”